Johnson & Johnson’s single dose COVID-19 vaccine will first be delivered in European countries on April 19..
The vaccine was the fourth to be approved by the European Medicines Agency after the Pfizer-BioNTech, Moderna and AstraZeneca vaccines.
It is already being administered in the United States and South Africa.
The EU’s agreement with the company is for 200 million doses which Johnson & Johnson has committed to deliver in 2021.
The Commission has said that 55 million doses are expected from the company by the end of June 2021 but the exact schedule of deliveries has not been made public.